As a counterpart, hypomethylated genes were enriched in basal cell carcinoma, breast cancer, gastric cancer, neurotrophin signaling pathway, and glycosaminoglycan biosynthesis (Figure 2B). This evidence concerns the gene BDNF and gastric cancer.